Novo Nordisk



Ebitda Zmiana Data
ANI Pharmaceuticals USD 14.85M 19.62M 2024-12
Aurora Cannabis CAD -25369000 7.78M 2024-12
Bausch Health Companies USD 851M 135M 2024-09
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Canopy Growth CAD -8628000 2.1M 2024-12
Corcept Therapeutics USD 25.54M 21.37M 2024-12
Drreddys Laboratories INR 23.31B 1.4B 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
GlaxoSmithKline GBP 2.08B 1.22B 2024-12
Merck USD 7.12B 1.06B 2024-12
Novartis USD 5.19B 319M 2024-12
Novo Nordisk 35.97B 1.19B 2024-09
Novo Nordisk DKK 35.97B 233M 2024-09
Pacira USD 50.78M 8.5M 2024-12
Perrigo USD 245.1M 49.4M 2024-12
Prestige Brands USD 98.83M 6.56M 2024-12
Sanofi EUR 4.25B 2.22B 2024-09
Supernus Pharmaceuticals USD 49.15M 11.8M 2024-12
Zoetis USD 894M 145M 2024-12



Novo Nordisk - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.